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Introduction
Malawi has one of the highest HIV prevalence in the world with 
10% of the adult population being infected [1]. As in many countries 
in sub-Saharan Africa, heterosexual intercourse is the predominant 
mode of HIV transmission in Malawi, accounting for 88% of all new 
infections [2]. Moreover, several studies have shown that a significant 
proportion of couples in steady relationships have serodiscordant 
status, ranging, for instance, from 7% in rural Uganda to 21% in 
Zambia [3-5]. Therefore, finding ways of reducing HIV transmission 
within serodiscordant couples is critical for controlling the epidemic. 
There has been a recent shift towards couples HIV testing and 
counseling as means for preventing within couple HIV transmission 
[2]. Becoming aware of one’s status not only allows for effective 
prevention efforts, such as initiation of antiretroviral treatment (ART) 
and pre-exposure prophylaxis (PrEP)[6,7], but several studies have 
shown that HTC among serodiscordant couples has been successful in 
terms of reducing risky sexual behavior [5,8-10].  
Although this prior work is encouraging, reductions in risky 
behavior may not be sustained over time. A recent report from Malawi 
found that serodiscordant couples who shared their HIV test results 
were more likely to report condom use but this change was only 
sustained over a short period of time [11]. This suggests that a longer 
duration after a couple’s HTC session may be associated with greater 
expectation that seroconversion occurred, reducing the perceived value 
of condom use. There is little incentive to use condoms if both partners 
believe they are positive. Therefore, reducing the duration between 
negative tests by increasing the frequency of couples HTC may prolong 
safe sexual behavior, and reduce the probability of seroconversion. 
Moreover, more frequent HTC increases exposure to the valuable 
HIV prevention information provided by counselors, which may help 
reinforce safe behavior.
This study is the first to evaluate the impact of repeated HTC 
among serodiscordant couples. From July 2011 to January 2013, 
we conducted a randomized controlled trial in Zomba, Malawi, by 
which half of the enrolled couples were randomly assigned to received 
repeated (quarterly) HTC and half were assigned to a control group. 
We measured how repeat HTC affected seroconversion, risky sexual 
behavior, and subjective beliefs about HIV status. 
Methods
Study Population and Enrollment
The study population was serodiscordant couples living in rural 
areas of Zomba, Malawi. We enrolled couples to participate in the study 
in two ways (Figure 1). First, we acquired a list of 3,400 previously 
identified discordant couples who participated in a prior study in 2011 
conducted by St. Luke’s Mission Hospital in Zomba, Malawi. In October 
of 2011, 150 of these serodiscordant couples were re-visited (those 
with adequate tracking information) and offered another couple HTC 
session, where both partners were re-tested. Couples that remained 
serodiscordant (had not divorced or seroconverted) were asked to be 
enrolled in the study and to complete a baseline survey. Of the 150 
couples contacted from the St. Luke’s program, 87 were jointly tested 
and 68 were identified as still serodiscordant. All 68 eligible couples 
agreed to be enrolled in the study. 
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Next, we enrolled additional couples through a door-to-door HTC 
campaign. We trained experienced HIV counselors who travelled door-
to-door, providing HTC services to all cohabitating couples with at least 
one partner between the ages of 15 and 55 across 129 Enumeration 
Areas (EAs) in Zomba district. EAs were randomly selected from a 
list of all EAs in Zomba district using a random number generator. 
Counselors went to all villages within an EA and visited all accessible 
households within a village. This process resulted in HIV testing of 3,929 
couples. Couples found to be serodiscordant were asked to participate 
in the study and all consenting couples were asked to immediately take 
part in a baseline survey, which captured information on risky sexual 
behavior, subjective beliefs about HIV, and other demographic and 
behavioral information that may affect the probability of risky behavior 
or HIV transmission. All survey questions were asked to both partners 
in separate survey sessions. Of the 277 couples that were found to be 
discordant, 269 agreed to participate in the study for a total of 337 
couples (including the St. Luke’s group). 
Random Assignment and Intervention
We randomly assigned 170 couples to receive couples HTC every 4 
months for the 12-month duration of the study (treatment group) and 
167 couples to receive no additional HTC until after study completion 
(control group) (Figure 1). In other words, couples assigned to the 
treatment group were visited for HTC 4 months and 8 months after 
enrollment, whereas couples assigned to the control group were not 
visited during this period. In order to ensure randomization resulted in 
balance between treatment and control groups on key characteristics, 
we employed a re-randomization technique, by which we re-
randomized couples until there were no statistical differences across 
groups in characteristics which we deemed to be important predictors 
of sexual behavior or seroconversion [12]. We ensured that couples 
were balanced on the following characteristics: number of children, age, 
gender of HIV+ member, education, land ownership, monthly income, 
employment status, intra-couple bargaining power, and risky-sexual 
behavior.
At each HTC session, both partners were counseled on safe sexual 
behavior and strategies for effective HIV management, and the HIV 
negative partner was given an HIV test. HIV tests were conducted with 
the Determine test kits and positive test results were verified using 
Uni-Gold and Bioline test kits. Couples in the treatment group who 
seroconverted during the intervention were dropped from subsequent 
treatment rounds. 
After 12 months, all couples were revisited to complete a follow-up 
survey similar to the baseline survey and receive a final HTC session 
(surveys were completed prior to HIV testing). Couples that were 
no longer cohabiting were not included in the study (although HTC 
services were still provided). 55 couples assigned to the treatment group 
and 31 couples assigned to the control group were lost to follow-up. 
Attrition was more common in the treatment group partly because this 
group had more visits and thus more opportunities to drop out of the 
study. In the treatment group, 23 couples divorced, 6 partners died, 10 
couples refused to continue with the study, 12 couples were not found, 
and 4 couples seroconverted during one of the two treatment waves. 
In the control group, 17 couples divorced, 3 partners died, 4 couples 
refused, and 7 couples were not found. This left 115 and 136 couples 
for analysis in the treatment and control group, respectively. We tested 
for differential attrition by measuring differences in key characteristics 
among those that attritted between treatment and control groups. We 
found no evidence that couples that attrited in the treatment group 
were significantly different from those that attrited in the control group 
(Appendix Table A1).
Outcomes and Measurement
We expected repeat testing to reduce seroconversion through two 
main channels: (i) reducing the perceived probability that seroconversion 
had occurred, thus creating more perceived benefit from condom use, 
(ii) being reminded about the effectiveness of condoms at preventing 
infection during counseling sessions. Therefore we measured the affect 
of the intervention on the main outcome (seroconversion) as well as 
the pathways to the main outcome (subjective expectations, knowledge 
about the disease, and risky sexual behavior). 
Seroconversion
We used HIV test results to measure seroconversion. We classified 
couples as having seroconverted if the partner who was HIV negative 
at baseline tested HIV positive at follow-up (or at any of the treatment 
waves if in the treatment group). We denominated this count data by 
the total number of people tested in each group in the follow-up HTC 
session. 
Risky Sexual Behavior
Risky sexual behavior measures were based on a series of questions 
asking respondents about sexual activity with their spouses. All 
questions were asked at both baseline and follow-up waves. All outcomes 
were created at the couple level. If responses were inconsistent within 
a couple, we used the response that indicated riskier sexual behavior 
since we expected under-reporting of risky behavior [13]. At follow-
up, responses were inconsistent between partners for between 20% and 
34% of couples depending on the outcome. There was no difference 
between treatment and control groups (Appendix Table A2). If the 
male was HIV positive, both partners were more likely to report safer 
behavior than if the female was positive. For most measures, the male 
Figure 1: Flow diagram of sample.
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first estimated unadjusted differences in proportions using tests for 
proportions. Next, we created a panel with two observations for each 
couple (baseline and after 12 months) and employed a difference-in-
differences analysis. This strategy accounts for baseline differences 
between treatment and control groups and models changes in self 
reported sexual behavior as function of intervention status. We used a 
pooled OLS model to assess differences in binary outcomes (“usually” 
or “ever” having had sex without a condom). To assess differences in 
categorical outcomes (frequency of sex and condom use) we used 
ordered probit models, and reported the average marginal effect of 
receiving repeated HTC for each category. 
Sensitivity Analyses
We conducted a series of sensitivity analyses to test the robustness of 
our results. First, couples from the treatment group who seroconverted 
during one of the treatment HTC rounds were not followed up for a 
post intervention questionnaire on sexual behavior and beliefs. Since 
these couples seroconverted, it is likely they were practicing particularly 
risky sex and their exclusion may have caused us to overstate the effects 
of the program. To account for this, we re-ran analyses with these 
couples included, with the assumption that they would have reported 
the riskiest behavior possible for all sexual behavior outcomes, which 
provided a more conservative estimate. 
Next, we tested the sensitivity of our seroconversion results to 
different assumptions about couples that were lost to follow-up. Since 
more couples in the treatment group attrited, if attriting couples were 
more prone to seroconversion, we may have overestimated the value of 
repeat testing for treatment couples. Similarly, if attriting couples were 
more prone to safe behavior, we may have underestimated the value of 
repeat testing. In order to test the range of possible outcomes if there 
had been no attrition we assumed 4 different scenarios about couples 
that attrited: 1) All couples in the control group seroconverted and 
no couples in the treatment groups seroconverted (Upper Bound), 2) 
no couples that attrited seroconverted (Middle Upper Bound), 3) all 
couples that attrited seroconverted (Middle Lower Bound), and 4) All 
couples in the treatment group seroconverted and no couples in the 
control group seroconverted (Lower Bound).
Next, we tested the sensitivity of our sexual behavior estimates to 
attrition in a similar way, by assuming that all couples lost to follow-up 
had the riskiest sexual behavior measures. Since the treatment group 
was more likely to attrite, this functions as a lower bound. 
Next, 32% of the control group couples got retested on their own 
outside of the intervention, which could cause us to underestimate the 
result of repeat testing. To account for this we also conduct a two stage 
least squares instrumental variable analysis, where we instrument the 
endogenous variable, repeat testing, with our exogenous treatment 
variable. We would expect the estimated effect of repeat testing to 
increase under this analysis since it helps to isolate for the causal effect 
of repeat testing as opposed to the causal effect of being in the treatment 
group. 
Next, since there was a considerable amount of within-couple 
inconsistencies on self-reported sexual behavior measures, we assessed 
the robustness of our results to different methodologies for constructing 
these measures. We tested five different methods of defining sexual 
behavior measures in place of using the riskiest reported behavior 
within a couple: 1) safest reported behavior within a couple, 2) male’s 
reported behavior, 3) female’s reported behavior, 4) HIV positive 
partners reported behavior, and 5) HIV negative partners reported 
behavior (Appendix Table A3).
reported safer measures than the female regardless of who was HIV 
positive (available upon request). 
Counselors first asked respondents if they “usually had sex without 
a condom” (“yes” or “no”). If either partner reported yes, the couple was 
classified as usually having had sex without a condom. Next, counselors 
asked respondents who reported not usually having sex without a 
condom if they “ever had sex without a condom” (“yes” or “no”). If 
either partner reported “yes” to this question or the prior question, 
the couple was classified as having had sex without a condom in the 
previous months. Next, all respondents were asked how frequently 
they used a condom in the past few months, with possible responses of 
never, sometimes, or usually. We classified couples as the least frequent 
value reported within the couple. Finally, respondents were asked how 
frequently they had sexual intercourse with their partner; 4+ times 
per week, 1-3 times per week, a couple of times a month, about once a 
month, or less than once a month. We classified a couple based on the 
most frequent value reported within the couple. We expected couples 
that received repeat HTC to report less risky sexual behavior measures.
Subjective Expectations and False Beliefs
We expected that repeat testing would reduce couples’ subjective 
expectations that seroconversion occurred, thus providing a greater 
incentive for safe sex. We also expected that greater exposure to HIV 
counseling could change false beliefs about HIV, which could also 
influence safer sexual behavior. For example, some people believe that 
they are immune to HIV. If these people are informed that nobody 
can be immune to HIV, they may act sexually safer in the future. Thus, 
we measured the impact of repeat HTC on subjective expectations of 
seroconversion as well as an array of beliefs about important biological 
and behavioral characteristics associated with HIV. We measured each 
couple’s subjective expectation of whether seroconversion occurred 
by asking respondents if they believed that the partner who was HIV-
negative upon enrollment was now HIV-positive. We expected that 
couples who received repeat HTC would be less likely to believe that 
seroconversion occurred.
Next, we had participants report their level of agreement with 
a series of statements about important biological and behavioral 
characteristics associated with HIV transmission. Specifically, we asked 
respondents if they agreed or disagreed with the following questions: 1) 
Some people can never get HIV even if they have unprotected sex with 
an HIV positive person; 2) It is impossible for a healthy looking person 
with no symptoms to have HIV; 3) If an HIV negative person has 
unprotected sex with an HIV positive person, the HIV negative person 
will always get HIV; 4) If a person has blood group O, it is impossible 
for them to get HIV from unprotected sex; 5) If a man is circumcised 
it is impossible for him to get HIV from unprotected sex; 6) If an 
HIV positive person is on ARV treatment, it is impossible for them 
to transmit the virus to an HIV negative person through unprotected 
sex; 7) A person with a healthy immune system cannot get HIV. We 
expected couples that received repeated HTC to have more accurate 
beliefs about HIV and to answer these questions more accurately.
Statistical Analysis
We conducted a series of statistical analyses to measure the impact 
of the repeated HTC program. All analyses were at the couple level. We 
used tests for proportions to measure differences between the treatment 
and control groups for seroconversion and beliefs (adding controls did 
not change results, available upon request). 
To measure the impact on risky sexual behavior outcomes, we 
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Results
Table 1 presents baseline demographic and socio-economic 
characteristics for the treatment and control group participants that 
were included in the follow-up questionnaire stratified by males and 
females. This table demonstrates that our randomization procedure was 
successful and groups were balanced on important characteristics prior 
the intervention. There were no statistical differences between groups 
on any of the characteristics measured. 
Table 2 shows differences in sexual behavior measures at baseline 
between treatment and control groups. We found that there were 
no statistical differences in sexual behavior measures prior to the 
intervention, although the treatment group may have been slightly 
more prone to risky sexual behavior, with a larger portion of couples 
reporting infrequent condom use. 
Only 9 of 246 couples seroconverted after one year, much fewer 
than expected (Table 3). There was slightly more seroconversion in 
the treatment group (5.2%) compared to the control group (2.3%), the 
opposite of what we expected, although the difference of 2.9% was not 
statistically significant (95% CI -2.0%, 7.9%). 
We found that couples that received repeat HTC were less likely to 
report risky sexual behavior at follow-up. Table 4 shows that the treatment 
group was 15.6 percentage points less likely to report usually having sex 
without a condom (p=0.013), 11.9 percentage points less likely to report 
ever having sex without a condom (p=0.047), and 17.3 percentage 
Males Females
 Control Treatment p-value Control Treatment p-value
Number of Children 4.3 4.3 0.937 3.3 3.4 0.704
Age 44.7 44.8 0.949 36.1 36.6 0.722
HIV+ 44.1% 51.3% 0.257 56.2% 48.7% 0.235
Monthly Income (Kwacha) 12,625 9,181 0.209 3,091 5,414 0.214
Education
No Education 10.9% 7.2% 0.330 16.8% 15.0% 0.702
Primary 62.0% 61.3% 0.905 56.8% 63.6% 0.297
Secondary 27.1% 31.5% 0.455 26.4% 21.5% 0.385
Work
No Work 23.9% 25.9% 0.716 48.1% 49.1% 0.881
Worked Half Time 35.8% 34.8% 0.870 30.4% 29.5% 0.877
Worked Full Time 40.3% 39.3% 0.872 21.5% 21.4% 0.992
Who Makes Decisions About FP 
Respondent alone 25.2% 17.9% 0.167 22.1% 21.4% 0.905
Spouse/partner alone 14.8% 10.7% 0.340 14.7% 17.9% 0.503
Respondent and spouse jointly 45.9% 53.6% 0.233 50.0% 44.6% 0.401
Respondent and someone else 0.0% 0.0% n/a 0.0% 0.9% 0.271
Never discussed 14.1% 17.9% 0.418 12.5% 15.2% 0.542
Statistical differences assessed using tests for proportions. No differences were statistically significant.
Table 1: Balance between treatment and control.
Control Treatment Difference
Usually Had Sex Without a Condom 66.9% 70.3% 3.4%
Ever Had Sex Without a Condom 83.5% 85.7% 2.3%
Frequency of Condom Use
Never 61.4% 64.2% 2.9%
Sometimes 15.2% 12.8% -2.3%
Usually 23.5% 22.9% -0.5%
Frequency of Sex
4+ times per week 23.1% 20.5% -2.6%
1-3 times per week 50.7% 59.8% 9.1%
couple of times a month 17.9% 14.3% -3.6%
About once a month 7.5% 5.4% -2.1%
Less than once a month 0.7% 0.0% -0.7%
Statistical differences assessed using tests for proportions. No differences were statistically significant.
Table 2: Sexual behavior measures at baseline.
Control Treatment Difference1
Number 3/131 6/115 N/A
Percent 2.3% 5.2% 2.9%
95% Confidence Interval -0.3% - 4.9% 1.2% - 9.3% -2.0% - 7.7%
1 Difference estimated using test for proportions
Table 3: Seroconversion.
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points less likely to report never using a condom (p=0.003). There was 
no difference between groups in frequency of sexual intercourse. Results 
were similar after adjusting for couple fixed-effects using difference-in-
difference models (Table 5). After adjustments, couples in the treatment 
group were 19 percentage points less likely to report usually having sex 
without a condom (p=0.010), 14 percentage points less likely to report ever 
having sex without a condom (p=0.015), 13 percentage points less likely 
to report never using a condom (p<0.001), and 13 percentage points more 
likely to report always using a condom (p=0.002). Couples who received 
repeat HTC also reported less frequent sexual intercourse after adjusting 
for couple fixed-effects (ordered probit coefficient of 0.545, p=0.026).
We found little difference between treatment and control groups in 
subjective expectations about seroconversion and false beliefs (Table 6). 
Contrary to our hypothesis, treatment couples were more likely to report 
that they believed seroconversion had already occurred, although these 
Control Treat Difference1 (95% CI)
Usually Had Sex Without a Condom 72/135 (53.3%) 43/114 (37.7%) -15.4%** (-28.0%, -3.2%)
Ever Had Sex Without a Condom 99/135 (73.3%) 70/114 (61.4%) -11.8%** (-23.6%, -.2%)
Frequency of Condom Use
Never 55/135 (40.7%) 27/115 (23.5%) -17.2%*** (-28.9%, -5.6%)
Sometimes 41/135 (30.4%) 43/115 (37.4%) 7.0% (-4.7%, 18.8%)
Usually 39/135 (28.9%) 45/115 (39.1%) 10.2%* (-1.5%, 23.0%)
 Frequency of Sex
4+ times per week 20/135 (14.8%) 10/113 (8.8%) -6.1% (-14.1%, 2.2%)
1-3 times per week 84/135 (62.2%) 67/113 (59.3%) -2.9% (-15.1%, 9.3%)
couple of times a month 21/135 (15.6%) 27/113 (23.9%) 8.2%* (-1.5%, 18.2%)
About once a month 7/135 (5.2%) 7/113 (6.2%) 1.0% (-4.8%, 6.8%)
Less than once a month 3/135 (2.2%) 2/113 (1.8%) -0.5% (-4.0%, 3.1%)
1Confidence intervals were calculated using tests for proportions
* P<0.1;  ** P<0.05; *** P<0.01
Table 4: Sexual behavior after 1 year (unadjusted).
Marginal Effects 95% Confidence Interval
Usually Had Sex Without a Condom1 -0.19*** (-0.33, -0.05)
Ever Had Sex Without a Condom1 -0.14** (-0.26, -0.03)
Frequency of Condom Use2
Never - 0.137*** (-0.20, -0.074)
Sometimes 0.007 (-0.02, 0.03)
Usually 0.130*** (0.05, 0.21)
Frequency of Sex2
4+ times per week -0.057** (-0.10, -0.01)
1-3 times per week -0.034 (-0.07, 0.07)
A couple of times a month 0.047** (0.004, 0.09)
About once a month 0.036** (0.00, 0.07)
Less than once a month 0.007 (-0.01,0.01)
1 Difference-in-difference estimates from linear regression with couple fixed-effects
2 Difference-in-difference estimates from ordered probit model with couple fixed-effects
** P<0.05
*** P <0.01
Table 5: Panel models with couple fixed effects.
 Male Female
Treat Control Treat Control
Subjective Expectations
Respondent thinks they are HIV positive 17.0% 9.9% 20.7% 11.9%
Beliefs (% that agree with each statement)
Some people can never get HIV even if they have unprotected sex with an HIV positive person 42.2% 44.5% 38.7% 42.2%
It is impossible for a healthy looking person with no symptoms to have HIV 95.5% 96.1% 96.5% 96.3%
If an HIV negative person has unprotected sex with an HIV positive person, the HIV negative person will 
always get HIV
61.5% 60.6% 71.8% 60.6%*
If a person has blood group O, it is impossible for them to get HIV from unprotected sex 22.6% 26.1% 26.9% 25.2%
If a man is circumcised it is impossible for him to get HIV from unprotected sex 10.1% 6.5% 10.2% 9.8%
If an HIV positive person is on ARV treatment, it is impossible for them to transmit the virus to an HIV negative 
person through unprotected sex
2.7% 7.9%* 6.3% 8.5%
A person with a healthy immune system cannot get HIV 2.7% 5.2%* 2.7% 5.2%
Statistical differences assessed using tests for proportions 
*p<0.1
Table 6: Subjective expectations and beliefs.
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results were not significant. There was little indication that repeat HTC had 
any effect on changing false beliefs, with similar portions in each group 
agreeing with each false statement. 
Sensitivity Analysis Results
Seroconversion: When we include couples that attrited in 
our seroconversion analysis with different assumptions about the 
behavior associated with attrition (Appendix Table A4), we found 
that the upper bound of the effect (all control group and no treatment 
couples seroconverted) was a nearly 20 percentage point reduction in 
seroconversion, and the lower bound of the effect (no control group 
and all treatment couples seroconverted) was a 34 percentage point 
increase in seroconversion. This wide range between lower and upper 
bounds further demonstrates that our results for seroconversion are 
inconclusive. 
Sexual behavior: We found little change in our sexual 
behavior estimates when we included treatment group couples that 
seroconverted during the intervention, with the assumption that they 
had the riskiest behavior levels (Appendix Table A5). When we defined 
inconsistencies between partners’ sexual behavior measures as the 
safer behavior reported of the two (instead of the riskiest), we found 
that the magnitude of our estimates decreased in all cases, and became 
insignificant for the outcome “usually having sex without a condom” 
(Appendix Table A6). When we defined inconsistencies between 
partners as the male’s reported sexual behavior, our results were similar 
to our main model results in Table 5 (Appendix Table A7). When 
we defined inconsistencies between partners as the female’s reported 
sexual behavior, the magnitude of our estimates decreased in all cases, 
and became insignificant for the outcome “usually having sex without 
a condom” (Appendix Table A8). When we defined inconsistencies 
between partners as the HIV-positive partner’s reported sexual 
behavior, results were similar to our main model results (Appendix 
Table A9). When we defined inconsistencies between partners as the 
HIV-negative partner’s reported sexual behavior, the magnitude of 
our estimates decreased in all cases, and became insignificant for the 
outcome “usually having sex without a condom” and “ever having sex 
without a condom” (Appendix Table A10). 
When we used our treatment variable as an instrument for receiving 
repeat testing over the year, we found the impact of repeat testing 
on risky sexual behavior was substantially larger (Appendix, Table 
A11). The local average treatment affect for usually and ever having 
sex without a condom was a 37 and 29 percentage point reduction, 
respectively. The local average treatment affect was also much larger 
for frequency of condom use with an estimated 40 percentage point 
reduction in “never” using a condom. These increases in coefficient 
magnitude add confidence that our results are driven by repeat testing. 
Finally, when we assumed that all couples that attrited had the 
riskiest sexual behavior measures (Appendix, Table A12), we found 
that our estimates decrease since more treatment group couples 
attrited. However, the direction of these lower bound estimates 
remains consistent with our main model, although the magnitude 
and significance levels decrease. Overall, these sensitivity analyses 
corroborated our results that repeat HTC may increase condom use, 
although they added ambiguity to the magnitude of our estimates. 
Discussion
This study was the first to measure the impact of repeat HTC 
among serodiscordant couples. Overall, our findings are mixed. On 
the one hand, couples that received repeated HTC generally reported 
greater condom use, a result that was robust to a variety of estimation 
methods. However, there was no difference in couples’ expectations that 
seroconversion had occurred at follow-up, which is what we expected 
to be the pathway to reducing risky behavior. More importantly, there 
was no evidence that repeat testing reduced seroconversion. Therefore, 
our findings that repeat HTC reduced risky sexual behavior should be 
interpreted with caution. 
There are a variety of possible explanations for why our results for 
sexual behavior are not consistent with biological and belief outcomes. 
First, it is important to note that this study was highly underpowered 
to detect differences in seroconversion. Previous studies reported much 
more frequent seroconversion [8,14] and we estimated a 20% annual 
seroconversion rate from the St. Luke’s sample. Given the rarity at which 
seroconversion occurred in our sample, our estimates are inconclusive. 
Second, couples in the treatment group had more interactions with 
counselors who advocated condom use at each visit. This could have 
created a greater incentive for treatment couples to report consistent 
condom use, even if it was not happening in reality. Control couples 
had less interaction with counselors and may have felt less inclined to 
appease them with false reports of consistent condom use. 
Third, it is possible that the intervention reduced risky sexual 
behavior within the couple, but increased risky sexual behavior with 
non-primary partners. This could lead to both increased condom use 
within the couple and increased HIV incidence in the treatment group. 
One aspect that likely dulled the effect of the intervention is that 
32% of the HIV negative partners in the control group got an additional 
HIV test at a health facility sometime between enrollment and follow-
up. In other words, many people in the control group sought out the 
intervention on their own. Although we conducted an instrumental 
variable analysis to address this issue statistically and get at the causal 
effect of repeat testing, it is clear that some repeat testing occurs 
naturally and a costly intervention may not be necessary.
Another possibility for why we do not find evidence that repeat 
testing prevents seroconversion is that our time period was not 
long enough. Our theory was that a longer time period between 
tests increases the perception that seroconversion already occurred. 
However, it is possible one year is not a long enough duration to see an 
effect. For example, maybe 4 months compared to 12 months between 
tests is not a big enough difference, and 4 months compared to 24 
months or 36 months would produce a larger effect. 
Serodiscordancy among heterosexual couples in Sub-Saharan Africa 
contributes to a large portion of new HIV transmission in the region. 
We find evidence that repeat HTC increase (self-reported) condom use, 
although this effect is inconsistent with our subjective expectation and 
biological findings. Future work is needed to fully understand whether 
repeat HTC is an effective tool for reducing seroconversion.
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